Corvus Pharmaceuticals (CRVS) had the highest return between March 28, 2023 and June 30, 2023 by a small-cap US stock, returning 252.4%.
| ASSET | DATE | % RETURN |
|---|---|---|
Corvus Pharmaceuticals (CRVS) | 3/28/2023 - 6/30/2023 | 252.42% |
Applied Opt (AAOI) | 3/28/2023 - 6/30/2023 | 238.64% |
Bit Digital (BTBT) | 3/28/2023 - 6/30/2023 | 205.26% |
Eyepoint Pharmaceuticals (EYPT) | 3/28/2023 - 6/30/2023 | 205.26% |
LifeMD (LFMD) | 3/28/2023 - 6/30/2023 | 204.2% |
National CineMedia (NCMI) | 3/28/2023 - 6/30/2023 | 180.83% |
Ads Tec Energy (ADSE) | 3/28/2023 - 6/30/2023 | 167.56% |
P3 Health Partners (PIII) | 3/28/2023 - 6/30/2023 | 164.6% |
Nano X Imaging (NNOX) | 3/28/2023 - 6/30/2023 | 162.1% |
Eos Energy Enterprises (EOSEW) | 3/28/2023 - 6/30/2023 | 159.26% |
Olema Pharmaceuticals (OLMA) | 3/28/2023 - 6/30/2023 | 157.26% |
Opendoor Technologies (OPEN) | 3/28/2023 - 6/30/2023 | 156.05% |
Pulse Biosciences (PLSE) | 3/28/2023 - 6/30/2023 | 152.09% |
A2Z Smart Technologies (AZ) | 3/28/2023 - 6/30/2023 | 138.68% |
Weave Communications (WEAV) | 3/28/2023 - 6/30/2023 | 129.07% |
SS Innovations International Inc Common Stock (SSII) | 3/28/2023 - 6/30/2023 | 121.43% |
Vera Therapeutics (VERA) | 3/28/2023 - 6/30/2023 | 120.77% |
Eos Energy Enterprises (EOSE) | 3/28/2023 - 6/30/2023 | 115.92% |
Phathom Pharmaceuticals (PHAT) | 3/28/2023 - 6/30/2023 | 114.69% |
Evolv Technologies (EVLV) | 3/28/2023 - 6/30/2023 | 111.27% |
Root (ROOT) | 3/28/2023 - 6/30/2023 | 109.86% |
Opera (OPRA) | 3/28/2023 - 6/30/2023 | 109.67% |
Bioventus (BVS) | 3/28/2023 - 6/30/2023 | 109.42% |
Xeris Pharmaceuticals (XERS) | 3/28/2023 - 6/30/2023 | 107.94% |
Pharvaris (PHVS) | 3/28/2023 - 6/30/2023 | 106.27% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
